Bispecific Antibodies Across Hematologic Malignancies: Nursing Considerations and Skill-Based Training for Clinical Integration

Improve your knowledge on bispecific antibodies in hematologic malignancies, including essential information on their mechanisms of action, clinical considerations, and safety profiles. This on-demand webcast with accompanying slides includes faculty insights on bispecific antibodies for multiple myeloma and B-cell lymphoma, highlighting current evidence, treatment pathways, and strategies for effective patient management.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an education grant from Janssen Biotech, Inc. administered by Janssen Scientific Affairs, LLC.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC